Skip to main content
Premium Trial:

Request an Annual Quote

Nicholas Naclerio, Tom Willis, Mostofa Ronaghi, Kim Blickenstaff, Jacqueline Barton

Premium

Nicholas Naclerio has been appointed president of ParAllele BioScience, the company said last week. Naclerio comes to the South San Francisco genotyping company from a stint as an independent consultant for life sciences and venture capital companies. Before that, he was chief business officer of protein chip company Zyomyx between November 2001 and early 2002. Previously, Naclerio was an executive at Motorola, where he founded the company’s life sciences business unit and led the launch of its CodeLink microarray platform between the late 1990s and 2001. He was an assistant director at the US government’s Defense Advanced Research Projects Agency before joining Motorola. Naclerio has also served on the boards of Orchid BioScience, Genometrix, the SNP Consortium, and Clinical Microsensors, which Motorola acquired in 2000. Tom Willis, Par-Allele’s current president, has been appointed chief scientific officer. Mostofa Ronaghi, a co-founder of the company, will leave the board of directors, and will join the company’s scientific advisory board.



Kim Blickenstaff joins the board of directors of GeneOhm Sciences, a San Diego-based company commercializing a biochip-based diagnostic technology invented by Jacqueline Barton of the California Institute of Technology. Blickenstaff is co-founder, president, and chief executive officer of Biosite.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.